National Institute of Diabetes and Digestive and Kidney Diseases; Notice of Closed Meetings, 29222-29223 [2019-13172]
Download as PDF
<![CDATA[
29222
Federal Register / Vol. 84, No. 120 / Friday, June 21, 2019 / Notices
Date: July 23, 2019.
Time: 1:00 p.m. to 3:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, Two
Democracy Plaza, 6707 Democracy
Boulevard, Bethesda, MD 20892 (Telephone
Conference Call).
Contact Person: Thomas A. Tatham, Ph.D.,
Scientific Review Officer, Review Branch,
DEA, NIDDK National Institutes of Health,
Room 7021, 6707 Democracy Boulevard,
Bethesda, MD 20892–5452 (301) 594–3993,
tathamt@mail.nih.gov.
Name of Committee: National Institute of
Diabetes and Digestive and Kidney Diseases,
Special Emphasis Panel; PAR–18–108:
NIDDK Exploratory Clinical Trials for Small
Business (R44).
Date: July 24, 2019.
Time: 11:30 a.m. to 1:30 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, Two
Democracy Plaza, 6707 Democracy
Boulevard, Bethesda, MD 20892 (Telephone
Conference Call).
Contact Person: Ann A. Jerkins, Ph.D.,
Scientific Review Officer, Review Branch,
DEA, NIDDK National Institutes of Health,
Room 7119, 6707 Democracy Boulevard,
Bethesda, MD, 20892–5452 (301) 594–2242,
jerkinsa@niddk.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.847, Diabetes,
Endocrinology and Metabolic Research;
93.848, Digestive Diseases and Nutrition
Research; 93.849, Kidney Diseases, Urology
and Hematology Research, National Institutes
of Health, HHS)
Dated: June 17, 2019.
Melanie J. Pantoja,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2019–13169 Filed 6–20–19; 8:45 am]
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
jspears on DSK30JT082PROD with NOTICES
National Institute on Alcohol Abuse
and Alcoholism; Notice of Closed
Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
18:30 Jun 20, 2019
Jkt 247001
Name of Committee: National Institute on
Alcohol Abuse and Alcoholism Special
Emphasis Panel, NIAAA Member Conflict
Applications—Clinical & Treatment Services.
Date: July 15, 2019.
Time: 10:00 a.m. to 12:30 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
National Institute on Alcohol Abuse and
Alcoholism, 6700B Rockledge Drive, Room
2120, Bethesda, MD 20892, (Telephone
Conference Call).
Contact Person: Anna Ghambaryan, M.D.,
Ph.D., Scientific Review Officer, Extramural
Project Review Branch, Office of Extramural
Activities, National Institute on Alcohol
Abuse and Alcoholism, 6700B Rockledge
Drive, Room 2120, Bethesda, MD 20892, 301–
443–4032, anna.ghambaryan@nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.271, Alcohol Research
Career Development Awards for Scientists
and Clinicians; 93.272, Alcohol National
Research Service Awards for Research
Training; 93.273, Alcohol Research Programs;
93.891, Alcohol Research Center Grants;
93.701, ARRA Related Biomedical Research
and Research Support Awards, National
Institutes of Health, HHS)
Dated: June 17, 2019.
Melanie J. Pantoja,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2019–13171 Filed 6–20–19; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute of Diabetes and
Digestive and Kidney Diseases; Notice
of Closed Meetings
BILLING CODE 4140–01–P
VerDate Sep<11>2014
would constitute a clearly unwarranted
invasion of personal privacy.
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute of
Diabetes and Digestive and Kidney Diseases
Special Emphasis Panel; O’Brien Urology
Centers.
Date: July 10–11, 2019.
Time: 8:00 a.m. to 12:30 p.m.
PO 00000
Frm 00066
Fmt 4703
Sfmt 4703
Agenda: To review and evaluate grant
applications.
Place: Marriott Wardman Park Washington
DC Hotel, 2660 Woodley Road NW,
Washington, DC 20008.
Contact Person: Jason D. Hoffert, Ph.D.,
Scientific Review Officer, Review Branch,
DEA, NIDDK, National Institutes of Health,
Room 7343, 6707 Democracy Boulevard,
Bethesda, MD 20817, (301) 496–9010,
hoffertj@niddk.nih.gov.
This notice is being published less than 15
days prior to the meeting due to the timing
limitations imposed by the review and
funding cycle.
Name of Committee: National Institute of
Diabetes and Digestive and Kidney Diseases
Special Emphasis Panel; Beta Cell Program
Project.
Date: July 16, 2019.
Time: 12:00 p.m. to 3:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, Two
Democracy Plaza, 6707 Democracy
Boulevard, Bethesda, MD 20892, (Telephone
Conference Call).
Contact Person: Michele L. Barnard, Ph.D.,
Scientific Review Officer, Review Branch,
DEA, NIDDK, National Institutes of Health,
Room 7353, 6707 Democracy Boulevard,
Bethesda, MD 20892–2542, (301) 594–8898,
barnardm@extra.niddk.nih.gov.
This notice is being published less than 15
days prior to the meeting due to the timing
limitations imposed by the review and
funding cycle.
Name of Committee: National Institute of
Diabetes and Digestive and Kidney Diseases
Special Emphasis Panel; NIDDK, Exploratory
Clinical Trials for Small Business (R44
Clinical Trial Required).
Date: July 16, 2019.
Time: 12:00 p.m. to 1:30 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, Two
Democracy Plaza, 6707 Democracy
Boulevard, Bethesda, MD 20892, (Telephone
Conference Call).
Contact Person: Jason D. Hoffert, Ph.D.,
Scientific Review Officer, Review Branch,
DEA, NIDDK, National Institutes of Health,
Room 7343, 6707 Democracy Boulevard,
Bethesda, MD 20817, (301) 496–9010,
hoffertj@niddk.nih.gov.
This notice is being published less than 15
days prior to the meeting due to the timing
limitations imposed by the review and
funding cycle.
Name of Committee: National Institute of
Diabetes and Digestive and Kidney Diseases
Special Emphasis Panel; NIDDK IBDGC
Ancillary Studies.
Date: July 18, 2019.
Time: 11:00 a.m. to 2:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, Two
Democracy Plaza, 6707 Democracy
Boulevard, Bethesda, MD 20892, (Telephone
Conference Call).
Contact Person: Jian Yang, Ph.D., Scientific
Review Officer, Review Branch, DEA,
NIDDK, National Institutes of Health, Room
E:\FR\FM\21JNN1.SGM
21JNN1
Federal Register / Vol. 84, No. 120 / Friday, June 21, 2019 / Notices
7111, 6707 Democracy Boulevard, Bethesda,
MD 20892–5452, (301) 594–7799, yangj@
extra.niddk.nih.gov.
This notice is being published less than 15
days prior to the meeting due to the timing
limitations imposed by the review and
funding cycle.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.847, Diabetes,
Endocrinology and Metabolic Research;
93.848, Digestive Diseases and Nutrition
Research; 93.849, Kidney Diseases, Urology
and Hematology Research, National Institutes
of Health, HHS)
Dated: June 17, 2019.
Melanie J. Pantoja,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2019–13172 Filed 6–20–19; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HOMELAND
SECURITY
Federal Emergency Management
Agency
[Docket ID FEMA–2014–0022]
Technical Mapping Advisory Council
Federal Emergency
Management Agency, DHS.
ACTION: Committee Management; Notice
of Federal Advisory Committee Meeting.
AGENCY:
The Federal Emergency
Management Agency (FEMA) Technical
Mapping Advisory Council (TMAC) will
meet in person on Wednesday, July 31,
2019 and Thursday, August 1, 2019 in
Arlington, VA. The meeting will be
open to the public.
DATES: The TMAC will meet on
Wednesday, July 31, 2019 from 8:45
a.m.–5 p.m. Eastern Daylight Time
(EDT), and Thursday, August 1, 2019
from 8:45 a.m.–5 p.m. EDT. Please note
that the meeting will close early if the
TMAC has completed its business.
ADDRESSES: The meeting will be held at
AECOM at 3101 Wilson Blvd., Ste 900,
Arlington, VA 22201. Members of the
public who wish to attend the meeting
must register in advance by sending an
email to FEMA-TMAC@fema.dhs.gov
(Attention: Michael Nakagaki) by 11
p.m. EDT on Tuesday, July 30, 2019.
Members of the public must check in at
the front desk of 3101 Wilson
Boulevard, Arlington, Virginia 22201
and will be provided with an escort to
the ninth floor; photo identification is
required.
For information on facilities or
services for individuals with disabilities
or to request special assistance at the
meeting, contact the person listed below
as soon as possible.
jspears on DSK30JT082PROD with NOTICES
SUMMARY:
VerDate Sep<11>2014
18:30 Jun 20, 2019
Jkt 247001
29223
To facilitate public participation,
members of the public are invited to
provide written comments on the issues
to be considered by the TMAC, as listed
in the SUPPLEMENTARY INFORMATION
section below. Associated meeting
materials will be available at
www.fema.gov/TMAC for review by
Friday, July 26, 2019. Written comments
to be considered by the committee at the
time of the meeting must be submitted
and received by Friday, July 26, 2019,
identified by Docket ID FEMA–2014–
0022, and submitted by one of the
following methods:
• Federal eRulemaking Portal: https://
www.regulations.gov. Follow the
instructions for submitting comments.
• Email: Address the email to: FEMATMAC@fema.dhs.gov. Include the
docket number in the subject line of the
message. Include name and contact
information in the body of the email.
• Mail: Regulatory Affairs Division,
Office of Chief Counsel, FEMA, 500 C
Street SW, Room 8NE, Washington, DC
20472–3100.
Instructions: All submissions received
must include the words ‘‘Federal
Emergency Management Agency’’ and
the docket number for this action.
Comments received will be posted
without alteration at https://
www.regulations.gov, including any
personal information provided.
Docket: For docket access to read
background documents or comments
received by the TMAC, go to https://
www.regulations.gov and search for the
Docket ID FEMA–2014–0022.
A public comment period will be held
on Wednesday, July 31, 2019, from 4
p.m. to 4:30 p.m. EDT and again on
Thursday, August 1, 2019, from 1 p.m.
to 1:30 p.m. EDT. Speakers are
requested to limit their comments to no
more than three minutes. The public
comment period will not exceed 30
minutes. Please note that the public
comment period may end before the
time indicated, following the last call
for comments. Contact the individual
listed below to register as a speaker by
close of business on Friday, July 26,
2019.
TMAC makes recommendations to the
FEMA Administrator on: (1) How to
improve, in a cost-effective manner, the
(a) accuracy, general quality, ease of use,
and distribution and dissemination of
flood insurance rate maps and risk data;
and (b) performance metrics and
milestones required to effectively and
efficiently map flood risk areas in the
United States; (2) mapping standards
and guidelines for (a) flood insurance
rate maps, and (b) data accuracy, data
quality, data currency, and data
eligibility; (3) how to maintain, on an
ongoing basis, flood insurance rate maps
and flood risk identification; (4)
procedures for delegating mapping
activities to State and local mapping
partners; and (5)(a) methods for
improving interagency and
intergovernmental coordination on
flood mapping and flood risk
determination, and (b) a funding
strategy to leverage and coordinate
budgets and expenditures across Federal
agencies. Furthermore, the TMAC is
required to submit an annual report to
the FEMA Administrator that contains:
(1) A description of the activities of the
Council; (2) an evaluation of the status
and performance of flood insurance rate
maps and mapping activities to revise
and update Flood Insurance Rate Maps;
and (3) a summary of recommendations
made by the Council to the FEMA
Administrator.
Agenda: During the two-day meeting,
TMAC members will conduct a final
review and discussion of the TMAC
2018 Annual Report and vote to submit
to FEMA. Day 2 of the meeting will
focus on tasking to the TMAC for 2019.
The TMAC will also receive public
input on the report recommendations
and content; the recommendations and
content will be posted to the FEMA
TMAC site prior to the meeting to
provide the public an opportunity to
review the materials. The full agenda
and related meeting materials will be
posted for review by Friday, July 26,
2019 at https://www.fema.gov/TMAC.
FOR FURTHER INFORMATION CONTACT:
Michael M. Grimm,
Assistant Administrator for Risk
Management, Federal Emergency
Management Agency.
Michael Nakagaki, Designated Federal
Officer for the TMAC, FEMA, 400 C
Street SW, Washington, DC 20024,
telephone (202) 212–2148, and email
michael.nakagaki@fema.dhs.gov. The
TMAC website is: https://www.fema.gov/
TMAC.
SUPPLEMENTARY INFORMATION: Notice of
this meeting is given under the Federal
Advisory Committee Act, 5 U.S.C. App.
In accordance with the Biggert-Waters
Flood Insurance Reform Act of 2012, the
PO 00000
Frm 00067
Fmt 4703
Sfmt 9990
[FR Doc. 2019–13170 Filed 6–20–19; 8:45 am]
BILLING CODE 9110–12–P
E:\FR\FM\21JNN1.SGM
21JNN1
]]>Agencies
[Federal Register Volume 84, Number 120 (Friday, June 21, 2019)]
[Notices]
[Pages 29222-29223]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2019-13172]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Institute of Diabetes and Digestive and Kidney Diseases;
Notice of Closed Meetings
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended, notice is hereby given of the following meetings.
The meetings will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5
U.S.C., as amended. The grant applications and the discussions could
disclose confidential trade secrets or commercial property such as
patentable material, and personal information concerning individuals
associated with the grant applications, the disclosure of which would
constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: National Institute of Diabetes and Digestive
and Kidney Diseases Special Emphasis Panel; O'Brien Urology Centers.
Date: July 10-11, 2019.
Time: 8:00 a.m. to 12:30 p.m.
Agenda: To review and evaluate grant applications.
Place: Marriott Wardman Park Washington DC Hotel, 2660 Woodley
Road NW, Washington, DC 20008.
Contact Person: Jason D. Hoffert, Ph.D., Scientific Review
Officer, Review Branch, DEA, NIDDK, National Institutes of Health,
Room 7343, 6707 Democracy Boulevard, Bethesda, MD 20817, (301) 496-
9010, [email protected].
This notice is being published less than 15 days prior to the
meeting due to the timing limitations imposed by the review and
funding cycle.
Name of Committee: National Institute of Diabetes and Digestive
and Kidney Diseases Special Emphasis Panel; Beta Cell Program
Project.
Date: July 16, 2019.
Time: 12:00 p.m. to 3:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, Two Democracy Plaza, 6707
Democracy Boulevard, Bethesda, MD 20892, (Telephone Conference
Call).
Contact Person: Michele L. Barnard, Ph.D., Scientific Review
Officer, Review Branch, DEA, NIDDK, National Institutes of Health,
Room 7353, 6707 Democracy Boulevard, Bethesda, MD 20892-2542, (301)
594-8898, [email protected].
This notice is being published less than 15 days prior to the
meeting due to the timing limitations imposed by the review and
funding cycle.
Name of Committee: National Institute of Diabetes and Digestive
and Kidney Diseases Special Emphasis Panel; NIDDK, Exploratory
Clinical Trials for Small Business (R44 Clinical Trial Required).
Date: July 16, 2019.
Time: 12:00 p.m. to 1:30 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, Two Democracy Plaza, 6707
Democracy Boulevard, Bethesda, MD 20892, (Telephone Conference
Call).
Contact Person: Jason D. Hoffert, Ph.D., Scientific Review
Officer, Review Branch, DEA, NIDDK, National Institutes of Health,
Room 7343, 6707 Democracy Boulevard, Bethesda, MD 20817, (301) 496-
9010, [email protected].
This notice is being published less than 15 days prior to the
meeting due to the timing limitations imposed by the review and
funding cycle.
Name of Committee: National Institute of Diabetes and Digestive
and Kidney Diseases Special Emphasis Panel; NIDDK IBDGC Ancillary
Studies.
Date: July 18, 2019.
Time: 11:00 a.m. to 2:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, Two Democracy Plaza, 6707
Democracy Boulevard, Bethesda, MD 20892, (Telephone Conference
Call).
Contact Person: Jian Yang, Ph.D., Scientific Review Officer,
Review Branch, DEA, NIDDK, National Institutes of Health, Room
[[Page 29223]]
7111, 6707 Democracy Boulevard, Bethesda, MD 20892-5452, (301) 594-
7799, [email protected].
This notice is being published less than 15 days prior to the
meeting due to the timing limitations imposed by the review and
funding cycle.
(Catalogue of Federal Domestic Assistance Program Nos. 93.847,
Diabetes, Endocrinology and Metabolic Research; 93.848, Digestive
Diseases and Nutrition Research; 93.849, Kidney Diseases, Urology
and Hematology Research, National Institutes of Health, HHS)
Dated: June 17, 2019.
Melanie J. Pantoja,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2019-13172 Filed 6-20-19; 8:45 am]
BILLING CODE 4140-01-P
